Form D · Other

Surgo Group LLC

New York, NY · CIK 0001670954

Offering snapshot reported Apr 18, 2018 · SEC filing

Reported sold: $3.12M
Investors reported: 18
Minimum accepted: $250K
First sale: Nov 15, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$0 → $3,120,125
Reported investors0 → 18

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 18, 2018	Amendment	$3,120,125	$3,120,125vs Nov 30, 2017	18	SEC filing
Nov 30, 2017	Initial	$0	No comparison	0	SEC filing
Nov 1, 2016	Initial	$2,674,990	No comparison	20	SEC filing
Nov 1, 2016	Amendment	$2,674,990	$0vs Nov 1, 2016	20	SEC filing

Offering details

Securities: Equity, Option to acquire
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $171K (estimated)
Finders' fees: $0
Form D file number: 021-299845

The sales commission amount referenced above is as of the date of this filing.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
National Securities Corporation	7569

Source: Form D, filed Apr 18, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Sam Fraenkel	Director
Travis Tillotson	Executive

Issuer details

Industry: Other (See others in industry)

Address:

291 Broadway 12th Floor
New York, NY, 10007